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1 
~~~~~~ ~~~ 
TTATGAAAGC 
~~~~~~~~~~ 
51 
TCGACCGAAA 
TCGAACTCAA 
~~~~~~~~~~ 
TCGATCGGTG 
~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~ 
TCCAACGCAT 
CAATTCAAA'T 
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GTAGGTTTTG 
TTCGATCAAT 
TTTCTAATTT 
CTGGAAATAT 
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GGTGTCGGTG 
TCAAATCGAC 
GGATTTCAGA 
TAATTGGATC 
50 
AGATCAGTGT 
GAACACGAAA 
~~~~~~~~ 
100 
AATCTGGGAG 
AAGCGGGCGG. 
....~~~.......~~ ~~~~M~~~~ ~~~~~~~~~~ ........~..~~~~ ~~~~gagaag 
101 
AAGGTAGCAG 
A. . .TATGAT 
ttgaccataa 
151 
AAAGATCATG 
GATGATCATA 
tcggaaaaat 
201 
GTTAAGTGAT 
GTTAAGCGAT 
actgagtgaa 
251 
CCGTCTGGTC 
CCATCCGTTC 
taatccgctc 
301 
TTATACACGG 
TTATACACGC 
ttctacttcc 
351 
TTACTTAGCA 
TTACTTAGCA 
ctacttagct 
401. 
GTTTATGGGT 
GTTTATGGGT 
gcttatggat 
451 
CAGTGGATTG 
CAGTGGGTTG 
acatggtttg 
501 
CCCTTACTTT 
ACCTTACTTT 
AATGTCGGAT 
GATGTCGGAT 
atcatttatc 
ATATGGACGA 
ATATAAACGA 
cggtcatgga 
CTAAAGAAAG 
CTAAAGAAAG 
ttgaagcaag 
ATCCTGCTAC 
ATCG'I‘GCTAC 
atcttactat 
TCGCCAACAC 
TCGCCAACTC 
ttgccaacac 
TGGCCGGTTT 
TGGCCTGTTT 
tggcccgttt 
CCTCGGCCAT 
CATTGGCCAT 
cctcggccac 
ATAACGCCGT 
ATAACACCGT 
acgacactgt 
TCTTGGAAAT 
TCTTGGAAAT 
TCATATGATG 
TCATGTGATG 
aacatgggtg 
ACGAGCCCCG 
ACGTGCACCG 
acgtgtctca 
CAATCCCTGC 
CAATCCCTCC 
caatccctcc 
GTAGTTCAGG 
GTTGTTCAGG 
gttgttcaag 
CTACATTCCT 
TTACATTCCT 
atatatccct 
ACTGGTTTTG 
ACTGGTTTTG 
actggttctg 
GAATGCGGCC 
GAATGTGGCC 
gaatgtggtc 
TGGATTCGTC 
TGGATTCATC 
gggcttcatc 
ACAGCCATCG 
ACAGCCATCG 
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A'I'C . . . . . . . 
ATCATGATCA 
ccggcggtcg 
ATTGATCCGG 
GTTGATGCGG 
gttg'atccag 
ACATTGCTTC 
GCATTGCTTC 
ccat_tgcttc 
ATCTCATTAT 
ATCTCATTAT 
atctcattat 
CACCTCCCTC 
CTTCTTCCTC 
actcttccta 
CCAATCTTGC 
CCAATCTTCG 
tcaagctagc 
ATCATGCCTT 
ATCATGCTTA 
accatgcctt 
CTCCAT'I'CGG 
CTCCATTCCT 
ctccactcat 
AAAGCACCAT 
AAAGCACCAT 
150 
. . . . .GAATG 
GCTGGTGAAA 
tggtcggaca 
200 
CGCCATTCTC 
CACCATTCTC 
taaccttctc 
250 
CGGCGATCCG 
CAGCGATCTG 
cagagatctg 
300 
CACCTTCCTT 
TACCTTCCTT 
tgcctacatc 
350 
CTCCTCTAGT 
CTCCTCTACC 
ctagtctagc 
400 
ATCCTCACTG 
ATCCTCACTG 
gtcctcactg 
450 
TAGTGAGTAC 
TAGTGAGTAC 
tagcaactac 
500 
CTCTCCTCAC 
TTCTTCTCAC 
ttctcctcac 
550 
GCAAACACAA 
GCCAACACGA 
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cccgtatttc 
551 
ATTCACTCGA 
ATTCACTGGA 
gttcgattga 
601 
AGGACTTACT 
AGGAATTACT 
gcgcgt, 
651 
CATCTTGGTC 
CATTT‘I'GCTT 
ggttttgatt 
701 
ATGTTTCAGG 
ATATTTCAGG 
atatttccgg 
AGCCCGATCT 
AGCCCCATCT 
agtccaattt 
801 
'I‘GGTATCGTT 
GGGTCTCATT 
tggtcttctt 
851 
GATTTGGTTG 
GGTTCGGTTG 
gagctgcttg 
901 
TCCTTCATTA 
GCCTTCATAA 
acctttttcg 
951 
CCATTACGAT 
TCATTACGAT 
tcattatgat 
1001 
TCGACAGAGA 
TCGATAGAGA 
tcgataggga 
1051 
ACCCACGTGT 
ACACACGTGT 
tcttggaaat 
AAACGAGGAA 
AAACGAGGAG 
taacgatgaa 
CCACATACGA 
CCAATTTCAA 
..atctataa 
ATCATGTTAA 
ATCATGTTGA 
atcatgttca 
CAAGAAGTAC 
CAAGAAATAC 
caagaaatac 
TCACCGAGCG 
TCAGTGAGCG 
tcaaagaacg 
GCAGTGTTTT 
GCTGTGTTTT 
gccgtgtttt 
GGTGATGTGC 
GGTAATGCGC 
ggtagcgtgc 
TCGTAATCAC 
TAATGATCAC 
atgtgatcac 
TCAACCGAAT 
TCGACCGAAT 
tcaactgaat 
TTTCGGTCTC 
TTTCGGTCTC 
ctttggattc 
TGCACCATTT 
TGCATCATTT 
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tcagtcaccg 
GTTTACATTC 
GTTTACATTC 
gtttacattc 
ATTTCTTGAC 
ATTTCTTGAC 
acttcttaac 
CCTTAGGATT 
CCTTGGGCTT 
ccctaggatt 
GATAGATTTA 
CAAAGGTTTG 
gacaggtttg 
TGAGCGAATC 
TGAACGAATC 
tgagcggttt 
ACGGACTCAA 
ACGGGCTTAA 
atggaattaa 
ATGTATGGAG 
ATGTACGGAG 
atgtatggag 
TTATCTGCAC 
TTATCTCCAC 
cttcttgcac 
GGAACTGGAT 
GGAACTGGAT 
ggaactggat 
CTGAATCGGG 
CTGAATAGGG 
ctgaatagtg 
G‘I’TTCCCTAC 
GTTCCCGTAC 
Figure 18 
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gaatcaccat 
CTAGAACTCA 
CTAAAGCCAA 
cgaaaagcaa 
AACACGCCTG 
AACACCCCTG 
aacccacctg 
TCCTTTATAC 
TCCTTTATAC 
tcctttatac 
CCAACCACTT 
CCAACCACTT 
ccaaccactt 
CAGGTTGCGT 
CAGG‘I‘CGTGC 
caggtcttcc 
GTTTCTTGTA 
GTTTCTTGTA 
agttgctgta 
TTCCAGTGAT 
CCCCAGTGGT 
ttccggtatt 
CACACACATC 
CACACCCATC 
cacacccatc 
CAAAGGAGCC 
CAAAGGAGCC 
'cagaggggcc 
TTTTCCACGA 
T'GTTCCATGA 
ttttccatga 
ATTCCACATT 
ATTCCACATT 
tccaacacaa 
600 
GTCCCAGCTC 
GTCCCAGCTC 
gtccaaactc 
650 
GTCGAATCCT 
GTCGAATCTT 
gtcggctgtt 
700 
CTCTTAACGA 
CTCTTGACCA 
ctcttgacaa 
750 
TGATCCATTG 
‘TGATCCGTTG 
cgaccccatg 
800 
TATCAGATCT 
TATCGGATGT 
tttcggatct 
850 
CAAACAAAAG 
GCGAAAAAAG 
gcaaataaag 
900 
AGGTCTGAAT 
TGGGCTGAAT 
aggcgtattt 
950 
TGTCGTCACC 
TGTCTTCGCC 
agtcgtcgcc 
1000 
TTGACCACAA 
TTGACTACAA 
ttgtcagcaa 
1050 
CGTTACACAC 
CGTCACTCAC 
tgttacacac 
1100 
ATCATGCAAA 
ATCATGCAAA 
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actcatgtca 
1101 
GGAGGCAAGC 
GGAGGCGAGC 
ggaggcaagg 
1151 
ACAGGACTCC 
ATAGGACTCC 
acaggactcc 
1201 
TACATCGAGC 
TACATCGAGC 
tacatcgagc 
1251 
TAAAATGTAA 
TAAAATGTGA 
taaattgtga 
1301 
CCCTTTTGTA 
TTTTGTAAGA 
acgtttgttc 
1351 
AATAAGTAAA 
AAAAAAAAAA. 
aagccaggcg 
1401 
AATACGCTAA 
tgcatcattt 
GAGGCCATCA 
GACGCAATAA 
gatgcaatca 
ATTTTTCAAA 
GTTTTACAAA 
aattttaaaa 
AAGATGCAGA 
CAGATGAAGA 
ctgat. . 
TCGATGATGG 
TACGAGCTGA 
tcatatgcaa 
TGCTTGAATC 
TAAATAAATA 
tatgtataat 
TCTTTGAGTG 
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gttttcatac 
AGCCAATCTT 
AGCCGGTGTT 
agccaatctt 
GCAATGTGGA 
GCAATGTGGA 
gcaatgtgga 
CAGCAAGCAC 
TAAGAAGCAC 
.agcaagctc 
AGTTTAGTTG 
GTACGTAGTA 
aatgcacatg 
GTTCTATTTC 
AATCTTGAAT 
aaaccgccgg 
AAGATGGGGA 
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attccacact 
GGGTGATTAC 
AGGGGAGTAT 
gggcgacttt 
GAGAGGCCAA 
GAGAGGCGAA 
9393999039 
AAAGGGACAT 
AAAGGTGTAT 
aaaggtgttt 
GAAA'I‘AATGA 
CGTTGTATGC 
cattttcaaa 
TTTATATGTT 
GAAGATAAAA 
tcctttggtt 
GCAGGAAACA 
atcatgcaaa 
1150 
AGGATGATCG 
CGGATGATCG 
tatatgatcg 
1200 
GGAATGCATT 
GGAATGCATC 
ggagtgcatg 
1250 
ATTGGTACCA 
ATTGGTACCA 
attggtatca 
1300 
CATGCAGCAT 
TTTTGTAACG 
ccctctagtt 
1350 
TTGTAAGATA 
AAAAAAAAAA 
gactatgcct 
1400 
AGCAGAATAT 
~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ 
aéécagttaa ataatatcgg tatgatgtgt aatgaaagta 
~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ 
tgtggttgtc tggttttgtt gctatgaaag 
Figure 1C 
aaagtatgtg gttgtcggtc 
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RECOMBINANT STOKESIA EPOXYGENASE 
GENE 
RELATED APPLICATIONS 
This application claims the bene?t of provisional appli 
cation 60/396,406, ?led Jul. 19, 2002, Which is incorporated 
herein in its entirety 
FIELD OF THE INVENTION 
The present invention relates to a novel nucleic acid 
molecule encoding an enzyme involved in fatty acid bio 
synthesis and modi?cation in plants and seeds. This nucleic 
acid molecule preferably originates from Slokesia laevis. 
The invention extends to genetically improved cost-effective 
raW materials for use in the ef?cient production of a variety 
of industrial products including coating, composites, adhe 
sives and plasticizers. 
BACKGROUND OF THE INVENTION 
Epoxy fatty acids contain oxygen bridges across adjacent 
carbon atoms at a single or multiples positions in the acyl 
chain, making them highly reactive and prone to cross 
linking. These properties make epoxy fatty acids valuable 
raW materials, particularly for epoxy coating and plasticiz 
ers. Currently, epoxidized soybean and linseed oils are 
produced by introducing an epoxy group across the double 
bond of polyunsaturated fatty acids. This is a costly process 
and it Would likely be more economical if the biosynthetic 
reactions in oilseed themselves converted the polyunsatu 
rated fatty acids into epoxy fatty acids. HoWever, there 
currently is no knoWn Way to produce a commercial oilseed 
that accumulates epoxy fatty acids by conventional breeding 
and genetics. 
Certain genotypes of several plant species accumulate 
high level of epoxy fatty acids in the seed oil. Epoxy fatty 
acids, like vemolic (E-12,13-epoxyoctadeca-E-9-enoic) and 
coronaric (E-9,10-epoxyoctadeca-E-12-enoic) acids, have 
been found as a component of the seed oil of species 
represented by a number of plant families such as Aster 
aceae, Euphorbiceae, pnagraceae, and Valerianaceae (Smith, 
1970). One of the highest knoWn accumulators of vemolic 
acid is Vernonia galamensis in Which vernolic acid con 
stitues 80% of triglyceride fatty acids (Perdue, 1989; Pascal 
and Correal, 1992; Thompson et al., 1994). Slokesia laevis 
is in the Asteraceae family, and the seed soil is also made up 
of about 60-70% vemolic acid (Gunstone, 1993). 
Many plants are knoWn to possess enzymes that transform 
unsaturated fatty acids into epoxy fatty acids (Gardner, 
1991; Gardner et al., 1991; Blee, 1998). The process by 
Which the seeds of certain species of Vernonia, Slokesia and 
Euphorbia appears to be due to an enzyme not present in 
major commercial oilseeds. Biochemical studies by Bafor et 
al. (1993) indicate that developing seeds of these plants 
contain an enzyme knoWn as epoxygenase Which converts 
linoleic acid into vemolic acid in a one step reaction. 
Although many plants including soybeans have enzymes 
such as lipoxygenase and peroxygenase that can produce 
epoxy fatty acids in some disease resistance reactions (Blee, 
1998), they do not have mechanisms for accumulation of 
epoxy-triglycerides in their seeds unlike epoxy triglyceride 
accumulators such as Slokesia mentioned above (Bafor et 
al., 1993; Hildebrand et al., 2001). 
The original studies on epoxy fatty acid synthesis and 
accumulation in oilseeds by Bafor et al. (1993) indicated that 
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2 
the epoxy fatty acid that accumulated in seeds of E. lagas 
cae, vernolic acid, is synthesized by an epoxygenase enzyme 
Which is a P450 monooxygenase enzyme. It Was assumed 
that other epoxy fatty acid accumulators such as Vernonia 
similarly synthesized epoxy fatty acids by P450 monooxy 
genase enzymes. 
HoWever studies by Seither (1996), Seither, Avdiushko et 
al. (1996, 1997) indicated that delta12 fatty acid desaturase 
like enzymes are responsible for vernolic acid biosynthesis 
in epoxy fatty acid accumulators of the Asteraceae such as 
Vernonia, Crepis and Slokesia unlike the Euphobiacea 
epoxide accumulator, E. lagascae, Which relied on P450 
monooxygenase (Seither, 1996, Seither, Avdiushko et al., 
1996, Seither, Avdiushko et al., 1997). 
A seed speci?c P450 monooxygenase family enzyme Was 
cloned from Euphorbia lagascae. The international patent 
application WOO2/08269 deals With the description of an 
enzyme of the cytochrome P450 mono-oxygenase class that 
is responsible for the epoxide formation. It is encoded by a 
nucleic acid isolated from Euphorba lagascae developing 
seed cDNA library. This patent application also discloses the 
nucleotide and amino acid sequence of the cytochrome P450 
mono-oxygenase of Euphorba lagascae. The fatty acid 
compositions Were monitored, shoWing accumulation of 
epoxy fatty acids in transformed plants. 
Genes from Vernonia galamensis and Crepis palaeslina 
have been isolated, and When expressed in plants or yeast, 
the encoded proteins are capable of converting linoleic acid 
to vemolic acid (US. Pat. No. 5,846,784, WO 98/56922, 
U.S. Pat. No. 6,329,518 and WO 98/46762). 
U.S. Pat. No. 5,846,784 relates to a nucleic acid encoding 
Vernonia galamensis fatty acid modifying enzymes. This 
nucleic acid is used to transform microbial and soybean 
embryogenic cells. The expression of this nucleic acid 
results in production of altered levels of a Vernonia gala 
mensis fatty acid modifying enzyme in the transformed 
cells. 
WO 98/ 56922 international patent application claims the 
priority of the above cited U.S. patent, it contains further 
example dealing With the transformation of corn cells and 
Arabidopsis cells. The expression of the Vernonia fatty acid 
epoxidase has been monitored in Arabidopsis seeds. The 
putative vernolic acid represented about 1.5% of the total 
fatty acids. 
U.S. Pat. No. 6,329,518 and international patent applica 
tion WO98/46762 describe the isolation and characteriza 
tion of an isolated nucleic acid molecule Which encodes a 
fatty acid epoxygenase from Crespis palaeslina. They also 
describe a genetic construct comprising said nucleic acid 
molecule operatively linked to a promoter sequence that is 
capable to be transcribed. The protein encoded by this 
nucleic acid molecule is a delta12 epoxygenase polypeptide 
Which catalyses the epoxygenation of a carbon double bound 
in linoleic acid to form vernolic acid. 
HoWever, the epoxygenase activities from these last 
plants producing vemolic acid have been shoWn to be 
different from the E. lagascae enzyme. Unlike the E. lagas 
cae enzyme, they are related to the endoplasmic reticulum 
localized fatty acid desaturases (WO 94/ 11516). These fatty 
acid epoxygenase enzymes are related in sequence to the 
class of membrane bound enzymes responsible for fatty acid 
desaturation and fatty acid hydroxylation (Broun and Som 
erville, 1997). Therefore, there are tWo distinct classes of 
genes encoding enzymes capable of vemolic acid epoxide 
group formation, one that is cytochrome P450-dependant, 
and the other that is related to the fatty acid desaturases and 
hydrolases. 
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The epoxygenase responsible for vernolic acid production 
in Slokesia laevis developing seed is a novel protein. 
SUMMARY OF THE INVENTION 
The present invention relates to isolated nucleic acid 
molecules encoding plant enzymes involved in fatty acid 
modi?cation, these enzymes having sequence homology to 
membrane bound desaturases. One aspect of the present 
invention provides an isolated nucleic acid molecule Which 
encodes a delta 12-fatty acid epoxygenase enZyme compris 
ing an amino acid sequence Which is at least about 80% 
homologous to SEQ ID N02 or a homologue, an analogue 
or a derivative thereof Which has epoxygenase activity. It is 
preferred that the isolated nucleic acid molecule encodes an 
amino acid sequence Which is at least 90% identical to SEQ 
ID N02 or a homologue, analogue or derivative thereof. 
In a more preferred aspect, the isolated nucleic acid 
molecule encodes an amino acid sequence Which is at least 
95% identical to SEQ ID N02 or a homologue, analogue or 
derivative thereof. 
The isolated nucleic acid molecule of the invention shall 
in the most preferred aspect encodes an amino acid sequence 
Which is at least about 98% identical to SEQ ID N02 or a 
homologue, analogue or derivative thereof. 
The invention also provides an isolated nucleic acid 
encoding a delta 12 epoxygenase having the nucleotide 
sequence of SEQ ID No.1 or its complement. In another 
embodiment, the invention provides a polypeptide having 
the sequence of SEQ ID No.2 and having a delta12 epoxy 
genase activity. 
In another embodiment, the invention deals With a chi 
meric gene comprising the isolated nucleic acid encoding a 
delta 12 epoxygenase enZyme of the invention operably 
linked to at least one suitable regulatory sequence that alloW 
the expression of the coding sequence in a host cell. In a 
preferred aspect, the regulatory sequence of the chimeric 
gene alloW the expression of the coding sequence in a plant 
cell. In another preferred aspect, the regulatory sequence of 
the chimeric gene comprises the phaseolin promoter. 
In another embodiment, the invention provides a vector 
comprising the above cited chimeric gene. 
In a further aspect, the invention provides an isolated host 
cell comprising the chimeric gene of the invention or a 
vector according to the invention. These host cells can be 
selected from the group comprising fungi, bacteria, insect 
and plant cells. 
In another embodiment, the invention provides a trans 
genic plant comprising the chimeric gene or the vector of the 
invention. 
A still further aspect of the invention provides a method 
for producing delta12 epoxy fatty acids Which comprises: 
(i) transforming a host cell With the chimeric gene or the 
vector of the invention; 
(ii) groWing the transformed host cells of step (i) under 
conditions that are suitable for expression of the chi 
meric gene, Wherein the expression of the chimeric 
gene results in production of altered levels of fatty acid 
modifying enZyme in the transformed host cell. 
In a preferred embodiment, the cell transformed in step (i) 
of the above cited method is a plant cell. 
The invention further provides a method for producing 
delta12 epoxy fatty acids Which comprises the additional 
step of: 
(iii) regenerating the cell obtained by step (ii) into a plant 
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The invention also provides a method for producing a 
delta12-epoxygenase enZyme comprising the folloWing 
steps: 
(i) transforming a microbial or a plant cell With the 
chimeric gene or With the vector of the invention; 
(ii) groWing the transformed cells obtained from step (i) 
under conditions that results in expression of the delta 
12-epoxygenase enZyme. In a preferred embodiment, 
the disclosed method can be used to produce a Slokesia 
laevis L112-epoxygenase enZyme 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIGS. 1A-1C shoW an alignment of the Slokesia laevis 
epoxygenase cDNA With Veronia (SEQ ID N019) and 
Crepis epoxygenase eDNA (SEQ ID NO:10). 
FIGS. 2A-2D: GC-MS analysis of fatty acid derivatives 
from transgenic Arabidopsis seeds. (A) Chromatograms 
from transgenic Arabidopsis transformed With pCAMBIA 
1202 comprising the cDNA from Slokesia laevis. (B) Chro 
matograms from Arabidopsis seeds transformed With empty 
vector, pCAMBIA 1201 as a control. (C) Mass spectrum of 
the compound giving rise to peak 5 at 13.94 min. in 
chromatogram (A), and (D) a standard vernolic acid. M/Z, 
mass-to-charge ratio. 
FIGS. 3A-3B shoW (A) elution of Vemolic acid from a 
column at 13.957 min. and (B) a control. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The invention relates to isolated nucleic acid molecules 
homologous to all or a substantial portion of a fatty acid 
epoxygenase enZyme normally expressed in developing 
seeds of Slokesia laevis. The invention also relates to the 
construction of a chimeric gene comprising a nucleic acid 
molecule encoding a polypeptide highly homologous to the 
epoxygenase enZyme of Slokesia laevis operably linked in 
sense or antisense orientation to suitable regulatory 
sequences, Wherein expression of the chimeric gene results 
in production of altered levels of the epoxygenase enZyme in 
a transformed host cell. The invention also relates to a 
method of production of altered levels of epoxy fatty acid in 
a host transformed cell or in a transformed organism or 
tissue. 
The term “isolated nucleic acid molecule” refers to a 
polymer of RNA or DNA that is single- or doubled-stranded, 
Which may optionally include synthetic or modi?ed nucle 
otides. 
The terms “epoxy group”, “epoxy fatty acids”, “epoxi 
diZed fatty acid” or “the product of an epoxygenase” all refer 
to the introduction of an epoxyide bridge (an oxygen atom 
covalently bound to carbon atoms that are in turn covalently 
bond to each other, to form a three member ring that is part 
of a larger molecular structure) at the site of a double bond 
in the acyl chain of a fatty acid. 
“Delta12-epoxygenase” or “delta 12-epoxidase” refers to 
an epoxygenase enZyme Which catalyses the conversion of 
the delta 12-carbon bond of a fatty acid substrate to a delta 
12 epoxy group. 
“Vernolic acid” refers to the fatty acid 12,13-epoxyocta 
deca-9-cis-enoic acid Which contains eighteen carbon atoms, 
a cis double bond betWeen the 9 and the 10 carbon atoms, 
and an epoxy group betWeen the 12 and 13 carbon atoms. 
The term “delta. 12-epoxy fatty acid” refers to a fatty acid 
such as vemolic acid that contains an epoxy group betWeen 
the 12 and 13 carbon atoms. 
US 7,364,901 B2 
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“Homologue of a nucleotide sequence” is understood 
according to the invention to mean an isolated nucleic acid 
molecule Which is substantially the same as the nucleic acid 
molecule of the present invention or its complementary 
nucleotide sequence, notwithstanding the occurrence Within 
the sequence, of one or more nucleotide substitutions, inser 
tion, deletions or rearrangements. Preferably, a homologue 
contains no more than about 25 nucleotide changes, prefer 
ably from about 1-25, more preferably about 5 to 20 
nucleotide changes. 
An “analogue” of a nucleotide sequence refers to an 
isolated nucleic acid molecule Which is substantially the 
same as a nucleic acid molecule of the invention or its 
complementary nucleotide sequence, notWithstanding the 
occurrence of any non-nucleotide constituents not normally 
present in said isolated nucleic acid molecule. An analogue 
encodes a polypeptide having the same activity or function 
of a polypeptide of the invention. 
The term “derivative” of a nucleotide sequence refers to 
any isolated nucleic acid molecule Which contains signi? 
cant sequence similarity to another sequence or a part 
thereof. Preferably a derivative exhibits about 50 to about 
98% sequence similarity to the speci?ed nucleotide 
sequence, more preferably about 70 to about 95% sequence 
similarity, and most preferably about 80%, 90%, 95% or 
98% sequence similarity. 
The term “gene” refers to a nucleic acid molecule that 
expresses a speci?c protein, including regulatory 5' non 
coding sequences and 3' non coding. “Chimeric gene” refers 
to a gene that does not exist in nature, comprising the 
folloWing elements in 5' to 3' orientation: a promoter func 
tional in a host (preferably a plant) cell, as de?ned above, a 
polynucleotide of the invention and a terminator functional 
in said cell. Other elements, for example an enhancer(s), 
may also be present. These chimeric genes may be incor 
porated into vectors, as de?ned above. 
“Coding sequence” refers to a nucleotide sequence that 
codes for a speci?c amino acid sequence. 
“Regulatory sequences” refers to nucleotide sequences 
located upstream (5' non-coding sequences), Within or 
doWnstream (3' non-coding sequences) of a coding 
sequence, and Which in?uence the transcription, RNA pro 
cessing or stability, or translation of the associated coding 
sequence. Regulatory sequences may include promoters, 
translation leader sequences, introns, and polyadenylation 
recognition sequences. 
“Promoter” refers to a DNA sequence capable of control 
ling the expression of a coding sequence or functional RNA. 
The coding sequence is located 3' to the promoter sequence. 
The promoter consists of proximal and more distal upstream 
elements, the latter elements are often referred as enhancers. 
“Operably linked” refers to the association of nucleic acid 
sequences on a single nucleic acid fragment so that the 
function of one is affected by the other. A promoter that is 
operably linked With a coding sequence is capable of affect 
ing the expression of that coding sequence. Coding 
sequences can be operably linked to regulatory sequences in 
sense or antisense orientation. 
“Plant cell” is understood according to the invention to 
mean any cell derived from a monocotyledonous or a 
dicotyledonous plant and capable of constituting undiffer 
entiated tissues such as calli, differentiated tissues such as 
embryos, portions of monocotyledonous plants, monocoty 
ledonous plants or seeds. “Plant” is understood to mean any 
differentiated multicellular organism capable of photosyn 
thesis, more particularly monocotyledonous or dicotyledon 
ous plants. 
5 
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As regulatory terminator sequence or polyadenylation 
sequence, there may be used any corresponding sequence of 
bacterial origin, such as for example the nos terminator from 
Agrobaclerium Zumefaciens of plant origin, such as for 
example a histone terminator as described in European 
application EP 633 317. 
Standard recombinant DNA and molecular cloning tech 
niques used herein are Well knoWn in the art and are 
described more fully in Sambrook, 1., Fritsch, E. F. and 
Maniatis T. Molecular Cloning: A Laboratory Manual; Cold 
Spring Harbor Laboratory Press: Cold Spring Harbor, 1989), 
incorporated herein by reference. 
This invention relates to isolated plant polynucleotides 
encoding plant fatty acid modifying enZymes. The nucle 
otide sequence encoding Slokesia laevis epoxygenase 
enZyme is provided in SEQ ID No.1; and the deduced amino 
acid sequence is provided in SEQ ID No.2. Fatty acid 
epoxygenase enZyme genes from other plants can noW be 
identi?ed by comparison of random DNA sequences to the 
Slokesia laevis sequences provided herein. 
Plants are knoWn to accumulate a Wide diversity of 
unusual fatty acids, some of Which have industrial use. 
Epoxy fatty acids, such as vemolic acid, are an example of 
a an uncommon fatty acid that accumulates in triacylglyc 
erol of a feW plant species that is valuable for various 
industrial uses including as plasticiZers. Slokesia laevis seed 
oil is made up of about 60-70% vemolic acid (12,13-epoxy 
9-octadecenoic acid). cDNAs encoding epoxygenases from 
Crepispalaeslina (Lee. et al., 1998) and Vernonia galamen 
sis (HitZ, 1998) have been cloned and found to be members 
of a groWing family of delta12 fatty acid desaturase-like 
analogs that also includes hydroxylases, acetylenases and 
conjugases. 
Degenerate primers Were designed on the basis of con 
served sequences of these delta12 desaturase-like genes, and 
an apparent full-length epoxygenase gene from S. laevis Was 
isolated using RT-PCR and RACE strategies. The cDNA is 
1.4 kb (SEQ ID NO. 1), the ORF 1134 bp and it encodes 378 
amino acids. The similarities of this gene With epoxygenase 
of Vernonia and Crepis, delta 12 desaturase of soybean, FAD 
2-1 and FAD 2-2 are 84.3%, 69.4%. 50.4% and 56.2%, 
respectively. 
The amino acid sequence encoded by the cDNA clone 
disclosed in SEQ ID No.1 has been compared to the those 
amino acid sequences listed in GenBank using the BLAST 
program With standard parameters (Altschul et al., 1990). 
The sequence of the (8,11) linoleoyl desaturase of Calendula 
o?icinalis shoWs the highest homology percentage (80%) 
With SEQ ID No.2. The Crepis palaeslina delta12-epoxy 
genase presents a homology of 78% With the sequence of the 
invention. It does not shoW any other signi?cation homology 
With epoxygenase enZymes of other origin. 
The nucleic acid molecules of the instant invention and 
fragments thereof may be used to isolate cDNAs and genes 
encoding homologous fatty acids modifying enZymes from 
the same or other species. Examples of sequence-dependent 
protocols include but are not limited to, methods of nucleic 
acid hybridization, methods of DNA and RNA ampli?ca 
tion. 
The nucleic acid molecules of the instant invention may 
be used to create transgenic plants in Which the Slokesia 
laevis modifying enZyme is present at a higher level than 
normal or in cell types or developmental stages in Which it 
is not normally found. The over expression of the Slokesia 
laevis epoxygenase enZyme may be useful for causing the 
biosynthesis and accumulation of epoxy fatty acids in those 
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cells. It is particularly useful to over produce this epoxy fatty 
acids in the cells of the seeds of oilseed crop plants. 
Over expression of the Slokesia laevis delta 12-epoxyge 
nase enzyme may be accomplished by cloning the gene 
under the control of a strong promoter capable of directing 
the expression in the desired tissues at the desired stage of 
development. 
The present invention also relates to a cloning or expres 
sion vector for the transformation of a cell, and preferably a 
plant cell. The vector according to the invention comprises, 
in addition to the above chimeric gene, at least one origin of 
replication. This vector may consist of a plasmid, a cosmid, 
a bacteriophage or a virus, transformed by the introduction 
of the chimeric gene according to the invention. Such 
vectors for transforming cells are Well knoWn to persons 
skilled in the art and are Widely described in the literature. 
Preferably, the vector for transforming plant cells or plants 
according to the invention is a plasmid. 
The invention also provides a method of transforming 
plant cells by integration of at least one nucleic acid mol 
ecule or one chimeric gene as de?ned above, Which trans 
formation may be obtained by any knoWn in the art consists 
in bombarding cells or protoplasts With particles to Which 
DNA sequences are attached. Another art knoWn method 
consists in using, as means of transferring into the plant, a 
chimeric gene inserted into an Agrobaclerium rhizogenes Ri 
or Agrobaclerium Zumefaciens Ti plasmid. Other methods 
may be used, such as microinjection or electroporation, or 
direct precipitation by means of PEG. Persons skilled in the 
art can readily choose the appropriate method according to 
the nature of the cell or of the plant. 
The present invention also provides transformed plant 
cells or plants producing epoxy fatty acids and containing at 
least one chimeric gene according to the invention de?ned 
above. The subject of the invention also includes the plants 
containing transformed cells, in particular the plants regen 
erated from the transformed cells. The regeneration is 
obtained by any appropriate method Which depends on the 
nature of the species. For the methods of transforming plant 
cells and of regenerating plants, there may be mentioned in 
particular the folloWing patents and patent applications: US. 
Pat. Nos. 4,459,355, 4,536,475, 5,464,763, 5,177,010, 
5,187,073, EP 267 159, EP 604 662, EP 672 752, US. Pat. 
Nos. 4,945,050, 5,036,006, 5,100,792, 5,371,014, 5,478, 
744, 5,179,022, 5,565,346, 5,484,956, 5,508,468, 5,538,877, 
5,554,798, 5,489,520, 5,510,318, 5,204,253, 5,405,765, EP 
442 174, EP 486 233, EP 486234, EP 539 563, EP 674 725, 
WO 91/02071 and WO 95/06128., the relevant portions of 
Which are incorporated by reference. 
The constructs of the invention can be used to generate 
transgenic plants in any type of plant, i.e., monocots or 
dicots. The skilled practitioner, using methods knoWn in the 
art, can readily transform any plant type using the isolated 
DNA molecules and vectors of the invention. For example, 
a transgenic plant of the invention can be produced using 
A grobaclerium Zumefaciens mediated DNA transfer, prefer 
ably With a disarmed T-DNA vector, electroporation, direct 
DNA transfer, and particle bombardment. Techniques are 
Well knoWn in the art for introducing nucleic acids into 
monocots as Well as dicots, as are the techniques for 
culturing such plants and plant tissues and regenerating 
them. 
The constructs of the present invention can be used to 
generate transgenic plants, seeds or protoplasts, and may be 
used in any plant tissue, e.g., roots, stems, leaves, ?owers, 
stems, pollen, or seeds. 
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For some applications it may be useful to direct the instant 
Slokesia laevis delta 12-epoxygenase enZyme to di?ferent 
cellular compartments, or facilitate its secretion from the 
cell. If desired appropriate intracellular targeting sequences 
or signal sequences can be operrably linked to the chimeric 
sequences. 
The present invention also relates to the transformed 
plants derived from cultivating and/or crossing the above 
regenerated plants, as Well as the transformed plant seeds. 
The folloWing non-limiting examples illustrate the inven 
tion. 
EXAMPLE 1 
cDNA Cloning 
A partial Slokesia laevis epoxygenase cDNA fragment 
Was obtained using a RT-PCR kit (Promega) using RNA 
from developing seeds as a template. The PCR mixtures 
contained ~1 g of total RNA template, 0.2 mM dNTPs, 2.5 
U of AMV reverse transcriptase, 2.5 U of TH polymase and 
~1 M each of tWo degenerate primers described beloW. 
Reaction mixtures Were incubated in a thermocycler (Perkin 
Elmer, Model 2400) for 45 minutes at 48 degrees C., 
folloWed by 2 minutes at 94 degrees C. and 40 cycles of 30 
seconds at 94 degrees C., 30 seconds at 500 C. and 1 minute 
at 72 degrees C. The PCR primers used Were a 5' epoxy and 
3' epoxy Which represent tWo peptides sequences, 
CHECGHHA-SEQ 1D NO.3 and HDVTHTHV-SEQ 1D 
NO.4, Which peptide sequences are the conserved regions in 
amino acid sequences of desaturase-like epoxygenases of 
Crepis palaeslina and Vernonia galamensis and delta 12, 
extracted from the gel using Gel Extraction kit (Qiagen) and 
subcloned into the pGEM-T Easy vector (Promega). The 
DNA inserted had both strands sequenced. 
For determination of the full-length cDNA sequence, a 
RACE (Rapid Ampli?cation of cDNA Ends) strategy Was 
applied. A cDNA Was synthesiZed from poly (A) +RNA of 
developing seeds of S. laevis using a Marathon cDNA 
Ampli?cation Kit (Clontech). TWo primers from the 
sequence information of the partial cDNA fragment of S. 
laevis epoxygenase Were designed; 5' ST(CGCAACCTG 
GATTCGCTCACGCTCGG-SEQ 1D No.5, and 3' 
ST(CCCAGCTCAGGACTTACTCCACATACG-SEQ 1D 
No.6. The 5'-half and 3'-half of the cDNAs Were ampli?ed 
using the PCR conditions described in the user manual of the 
kit. 
Fractionation of the ampli?ed fragments, cloning and 
sequencing Were carried out as described above. 
The cDNA sequence (SEQ ID No.1) Was determined to be 
1134 bp. It Was not chimeric and did not contain any errors, 
Which Was proven by separate tWo PCRs With the most distal 
primer pairs and direct DNA sequencing on those PCR 
products. 
The ATG start site of the open reading frame for 378 
amino acids (SEQ ID N012) is at 93 and the stop codon is 
at 1227. 
EXAMPLE 2 
Cloning of Slokesia epoxygenase cDNA for Expression in 
Arabidopsis Zhaliana 
The epoxygenase cDNA of Slokesia Was expressed in 
Arabidopsis Zhaliana. A BsmBl site Was introduced at the 
?rst ATG and a Sinai site Was introduced at the end of the 
ORF (Qpen reading frame or coding sequence) of the cDNA 
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by PCR mutagenesis. The ORF sequence of the cDNA Was 
ampli?ed using tWo primers: StexpF (GACGCGTCTTC 
CCATGTCGGATTCATATGATG-SEQ ID NO. 7and 
StexpR (GACGCCCGGGVrACATTTTATGGTACCAAT 
ATGTCCC-SEQ ID NO.8, BmsBl and Smal sites are under 
lined), and cloned into the pGEM-T Easy vector and veri?ed 
by DNA sequencing. The BsmBl-Smal fragment covering 
the entire open reading frame of the cDNA Was cut out from 
pGEM-T Easy vector and ultimately cloned into the respec 
tive site of pPHI4752 vector, Which contains a phaseolin 
promoter cassette. The PstI fragment including the cDNA 
With the phaseolin cassette Was cut out from the pPHI 4752 
vector and cloned into the respective multi-cloning site of 
pcambiaCAMBIA 1201, T-DNA vector. 
This construct, pCAMBIA-ST Was transformed into 
Agrobaclerium Zumefaciens, strain C58 harboring GV3850 
vector by a triparental matings method. The original pCAM 
BIA 1201 Was also transformed into 8 Agrobaclerium 
EXAMPLE 3 
10 
0.8% Phytagar, pH 5.8). Surviving plantlets Were transferred 
into soil and T 2 seeds Were collected. 
EXAMPLE 4 
Lipid extraction: For lipid extraction, seeds Were ground in 
chloroform-methanol (2:1). The extracts Were brought to 
dryness under a N2 gas stream. The lipid residues Were 
10 immediately dissolved in a feW drops of diaZomethane and 
0.5 mL sodium methoxide solution and shaken for 45 
minutes at room temperature. The methyl ester fatty acids 
Were extracted in the hexane-upper layer (1 mL). The 
samples Were analyZed using gas chromatography-mass 
15 spectrometry or gas chromatography by injecting 1 micro 
liter or 5 microliters of hexane extract, respectively. 
To verify the enZymatic activity of the gene product, the 
protein Was expressed in seeds of A. Thaliana plants. In 
seeds of transgenic Arabidopsis, vemolic acid Was detected 
20 , . . . 
With GC-MS, but no vernol1c acid was detected in control 
_ _ _ _ plants transformed With the empty vector (FIGS. 1A-1C). 
Transformation of Arabzdopszs Zhalzana Plants as a Control. 
Arabidopsis Zhaliana ecotype Columbia plants Were Table 1: Seed oil fatty acid composition for transgenic 
transformed With the Agrobaclerium carrying pCAMBIA- Arabidopsis Zhaliana carrying the Slokesia laevis epoxyge 
ST or pCAMBIA 1201 using a simpli?ed dipping method 25 nase. Control seeds of vector transformed T2 Arabidopsis 
(Clough and Bent 1998). T1 seeds Were collected and seeds?he average of 2 replications. Plants 1 to 16 are T2 s 
cultured on selection media (MS salts, B5 vitamins, 1% d analyses of different epoxygenas transgenic plants. 
sucrose, 25 mg/L hygromycin, 500 mg/L cefotaxime and *Vaq/emolic acid. 
TABLE 1 
plant 16:0 16:1 18:0 18:1 18:2 18:3 20:0 20:1 22:0 22:1 Va* Total 
Seed Fatty Acid Contents (pg/mg D.W.) 
1 10.6 0.6 3.6 33.8 23.8 19.4 1.6 16.0 0.7 0.9 1.3 112.2 
2 9.6 1.1 4.6 69.1 20.2 19.4 2.2 32.2 0.7 15 5.1 165.6 
3 30.6 2.7 14.9 141.5 38.0 36.6 6.8 64.2 ND 3 3 10.6 349.1 
4 18.1 1 2 7.8 97.9 26.7 25.3 3.7 40.7 0.8 1.7 5.5 229.5 
5 15.7 1.0 6.9 65.7 34.6 28.2 3.5 36.4 1.0 2.0 2.9 197.9 
6 30.6 2.7 14.7 151.3 56.3 50.8 6.8 78.1 1.7 3.6 9.4 405.9 
7 20.4 1 9 7.7 83.1 28.0 27.7 2.7 33.6 0.7 1.2 5.3 212.3 
8 17.8 1 5 7.8 108.9 35.7 32.8 3.4 47.5 1.0 1.9 5.0 263.5 
9 18.1 1.6 8.4 113.3 21.8 25.6 3.2 47.5 1.6 1.6 7.0 249.8 
10 23.6 2.2 10.9 140.5 46.0 39.8 4.5 59.5 1.2 2.4 7.0 337.6 
11 17.9 1 4 8.0 80.3 46.6 38.3 3.9 45.3 1.4 2.2 3.7 248.9 
12 15.3 14 7.5 113.5 21.4 19.6 3.2 49.6 ND 1.9 6.2 239.6 
13 15.8 1 2 7.3 79.7 25.3 27.0 3.4 38.3 0.9 1.7 6.4 207.0 
14 21.1 1 6 9.0 106.6 34.2 31.4 3.8 48.7 1.0 1.9 7.0 266.1 
15 15.0 14 7.0 72.6 26.2 21.5 3.3 36.7 0.9 1.8 4.9 169.0 
16 17.4 15 7.2 59.8 28.0 28.7 3.4 31.3 1.0 1.6 5.8 185.8 
Average 18.8 1.6 8.3 94.9 32.1 29.5 3.7 44.1 0.9 1.9 5.8 241.2 
Ave. CTRL 23.5 1.8 8.3 76.3 60.9 40.0 3.4 33.9 1.3 1.5 0.0 253.8 
1 9.5 
2 5.8 
3 8.8 
4 7.9 
5 7.9 
6 7.5 
7 9.6 
8 6.8 
9 7.3 
10 7.0 
11 7.2 
12 6.4 
13 7.6 
14 7.9 
15 8.0 
16 9.4 
Average 7.8 
Ave. CTRL 
Seed Fatty Acid Composition (% of Total Fatty Acids) 
0.6 3.2 30.1 21.2 17.3 1.4 14.3 0.6 0.8 1.1 
0.7 2.8 41.7 12.2 11.7 1.3 19.4 0 4 0.9 3.1 
0.8 4.3 40.5 10.9 10.5 2.0 18.4 0.0 1.0 3.0 
0.5 3.4 42.7 11.6 11.0 1.6 17.7 0.3 0.8 2.4 
0.5 3.5 33.2 17.5 14.2 1.8 18.4 0.5 1.0 1.4 
0.7 3.6 37.3 13.9 12.5 1.7 19.2 0.4 0.9 2.3 
0.9 3.6 39.1 13.2 13.0 1.3 15.8 0.3 0.6 2.5 
0.6 3.0 41.4 13.6 12.5 1.3 18.0 0.4 0.7 1.9 
0.7 3.4 45.4 8.7 10.3 13 19.0 0.6 0.6 2.8 
0.7 3.2 41.6 13.6 11.8 13 17.6 0.4 0.7 2.1 
0.6 3.2 32.3 18.7 15.4 16 18.2 0.5 0.9 1.5 
0.6 3.1 47.4 8.9 8.2 14 20.7 0.0 0.8 2.6 
0.6 3.5 38.5 12.2 13.0 17 18.5 0 4 0.8 31 
0.6 3.4 40.0 12.8 11.8 14 18.3 0.4 0.7 2.6 
0.7 3.7 38.4 13.9 11.4 18 19.4 0.5 1.0 2.6 
0.8 3.9 32.2 15.1 15.5 18 16.9 0.5 0.9 3.1 
0.6 3.4 38.9 13.6 12.5 15 18.1 0.4 0.8 2.4 
0.7 3.3 31.0 24.3 15.9 13 13.5 0.5 0.6 0.0 
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EXAMPLE 5 
Slokesia epoxygenase Expression in Soybeans 
A soybean line expressing the Slokesia epoxygenase gene 
12 
EXAMPLE 6 
Isolation of an Analogue, Homolog or Derivative of Slokesia 
laevis Delta 12-Epoxygenase Gene 
. . 5 
$1515tiffrféagiibgggclglyfg?s gfvc?dvsgfofé 3113 Sequence similarity to the Szokesia lam-S delta 12_epOXy_ 
relative to control soybean somatic embryos FIGS 3A-2B genase gene 15 used to Isolate analogues’ homologs and 
Vemolic acid elutes from the Column at 13 957 min as derivatives of the delta 12-epoxygenase gene. Using probes 
designated by the arrow in FIGS 3A that are speci?c for the Slokesia laevis delta 12-epoxygenase 
As shoWn in Table 2, the vernolic acid accumulation in the 10 gene and hlgh stringency hybndlzanon and Wash Condmons’ 
Soy bean transgenic line 4128 was low’ but>10 fold more e.g., an example of highly stringent Wash conditions is 0.15 
than the Control (Table 2) M NaCl at 72° C. for about 15 minutes; an example of 
stringent Wash conditions is a 0.2><SSC Wash at 65° C. for 15 
TABLE 2 minutes (See, Sambrook et al. (1989) Molecular Clon 
15 ingiA Laboratory Manual (2nd ed.) Vol. 1-3, Cold Spring 
Production Of m?mréd sgyblf?l} sgm?tlic embryos from M116 4128 Harbor Laboratory, Cold Spring Harbor Press, N.Y., for a 
l . . . . . 
expressing 0 em gem epoxvgenase description of SSC buffer and description of stringency 
Somatic embryos vemolic acid (% oftotal fatty acids) conditions for nucleic acid hybridization), polynucleotide 
C l 0 09 20 sequences that are analogues, homologs or derivatives of the 
Smkesia zaesgtrspoxygenase 0 9; a; 0 20 delta 12-epoxygenase are isolated. In general, a signal to 
noise ratio of 2x (or higher) than that observed for an 
Data are means : STD (n = 6) unrelated probe in the particular hybridiZation assay indi 
cates detection of a speci?c hybridiZation. 
SEQUENCE LISTING 
<l60> NUMBER OF SEQ ID NOS: 1o 
<210> SEQ ID NO 1 
<211> LENGTH: 1406 
<212> TYPE: DNA 
<2l3> ORGANISM: Stokesia laevis 
<4oo> SEQUENCE: 1 
gtaggttttg ggtgtcggtg agatcagtgt tcgaccgaaa tccaacgcat tttctaattt 6O 
ggatttcaga aatctgggag aaggtagcag aatgtcggat tcatatgatg atcgaatgaa 120 
agatcatgat atggacgaac gagccccgat tgatccggcg ccattctcgt taagtgatct 180 
aaagaaagca atccctgcac attgcttccg gcgatccgcc gtctggtcat cctgctacgt 240 
agttcaggat ctcattatca ccttcctttt atacacggtc gccaacacct acattcctca 300 
cctccctcct cctctagttt acttagcatg gccggtttac tggttttgcc aatcttgcat 360 
cctcactggt ttatgggtcc tcggccatga atgcggccat catgccttta gtgagtacca 420 
gtggattgat aacgccgttg gattcgtcct ccattcggct ctcctcaccc cttacttttc 480 
ttggaaatac agccatcgaa agcaccatgc aaacacaaat tcactcgaaa acgaggaagt 540 
ttacattcct agaactcagt cccagctcag gacttactcc acatacgaat ttcttgacaa 600 
cacgcctggt cgaatcctca tcttggtcat catgttaacc ttaggatttc ctttatacct 660 
cttaacgaat gtttcaggca agaagtacga tagatttacc aaccactttg atccattgag 720 
cccgatcttc accgagcgtg agcgaatcca ggttgcgtta tcagatcttg gtatcgttgc 780 
agtgttttac ggactcaagt ttcttgtaca aacaaaagga tttggttggg tgatgtgcat 840 
gtatggagtt ccagtgatag gtctgaattc cttcattatc gtaatcactt atctgcacca 900 
cacacatctg tcgtcacccc attacgattc aaccgaatgg aactggatca aaggagcctt 960 
13 
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gaccacaatc 
ccacgtgttg 
ggccatcaag 
aatgtggaga 
agggacatat 
tgcagcatcc 
taagtaaatc 
aaaaaaaaaa 
gacagagatt 
caccatttgt 
ccaatcttgg 
gaggccaagg 
tggtaccata 
cttttgtatg 
tttgagtgaa 
aaaaaaaaaa 
<210> SEQ ID NO 2 
<211> LENGTH: 
<2l2> TYPE: 
<2l3> ORGANISM: Stokesia laevis 
3'78 
PRT 
<400> SEQUENCE: 2 
Met Ser Asp 
1 
Arg 
Ala 
Tyr 
65 
Pro 
Leu 
Asp 
Phe 
Leu 
145 
Thr 
Ile 
Asn 
Leu 
Asp 
225 
Thr 
Gly 
Leu 
Ala 
Ala 
Ile 
Val 
50 
Thr 
Val 
Gly 
Asn 
Ser 
130 
Glu 
Tyr 
Leu 
Val 
Ser 
210 
Leu 
Lys 
Leu 
Ser 
Leu 
Pro 
Pro 
35 
Val 
Tyr 
Tyr 
His 
Ala 
115 
Trp 
Asn 
Ser 
Val 
Ser 
195 
Pro 
Gly 
Gly 
Asn 
Ser 
275 
Thr 
Ser Tyr 
5 
Ile Asp 
Ala His 
Gln Asp 
Ile Pro 
Phe 
85 
Trp 
Glu 
100 
Cys 
Val Gly 
Lys Tyr 
Glu Glu 
Asp 
Pro 
Cys 
Leu 
His 
Cys 
Gly 
Phe 
Ser 
Val 
tcggtctcct 
ttccctacat 
gtgattacag 
aatgcattta 
aaatgtaatc 
cttgaatcgt 
gatggggagc 
aaaaaa 
Asp Arg 
Ala Pro 
Phe Arg 
40 
Ile 
55 
Ile 
Leu Pro 
Gln Ser 
His His 
Val Leu 
120 
His 
135 
Arg 
Tyr Ile 
150 
Thr Tyr 
165 
Ile 
180 
Met 
Gly Lys 
Ile Phe 
Ile Val 
Glu 
Leu 
Lys 
Thr 
Ala 
Phe Leu 
Thr Leu 
Tyr Asp 
200 
Glu 
215 
Arg 
Val Phe 
230 
Phe Gly 
245 
Ser Phe 
260 
Pro His 
Thr Ile 
Trp 
Ile 
Tyr 
Asp 
Val Met 
Ile Val 
Ser 
280 
Asp 
Arg Asp 
gaatcgggtt 
tccacattat 
gatgatcgac 
catcgagcaa 
gatgatggag 
tctatttctt 
aggaaacaag 
Met Lys 
10 
Asp 
Phe 
25 
Ser Leu 
Arg Ser Ala 
Thr Phe Leu 
Leu 
75 
Pro Pro 
Ile 
90 
Cys Leu 
Ala 
105 
Phe Ser 
His Ser Ala 
Lys His His 
Thr 
155 
Pro Arg 
Asn Thr 
170 
Asp 
Gly Phe Pro 
185 
Phe Arg Thr 
Glu Arg Ile 
Leu 
235 
Tyr Gly 
Met 
250 
Cys Tyr 
Ile 
265 
Thr Tyr 
Thr Glu Trp 
Phe Gly Leu 
ttccacgacg ttacacacac 
catgcaaagg aggcaagcga 
aggactccat 
gatgcagaca 
tttagttgga 
tatatgtttt 
cagaatataa 
His 
Ser 
Val 
Leu 
60 
Val 
Thr 
Glu 
Leu 
Ala 
140 
Gln 
Pro 
Leu 
Asn 
Gln 
220 
Lys 
Gly 
Leu 
Asn 
Leu 
Asp 
Asp 
Trp 
45 
Tyr 
Tyr 
Gly 
Tyr 
Leu 
125 
Asn 
Ser 
Gly 
Tyr 
His 
205 
Val 
Phe 
Val 
His 
Trp 
285 
Asn 
Met 
Leu 
30 
Ser 
Thr 
Leu 
Leu 
11O 
Thr 
Thr 
Gln 
Arg 
Leu 
190 
Phe 
Ala 
Leu 
Pro 
His 
270 
Ile 
Arg 
ttttcaaagc 
gcaagcacaa 
aataatgaca 
gtaagataaa 
tacgctaaaa 
Asp Glu 
15 
Lys Lys 
Ser Cys 
Val Ala 
Ala Trp 
Trp Val 
95 
Trp Ile 
Pro Tyr 
Asn Ser 
Leu Arg 
160 
Ile 
1'75 
Leu 
Leu Thr 
Asp Pro 
Leu Ser 
Val Gln 
240 
Val 
255 
Ile 
Thr His 
Lys Gly 
Val Phe 
1020 
1080 
1140 
1200 
1260 
1320 
1380 
1406 
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290 295 300 
His Asp Val Thr His Thr His Val Leu His His Leu Phe Pro Tyr Ile 
305 310 315 320 
Pro His Tyr His Ala Lys Glu Ala Ser Glu Ala Ile Lys Pro Ile Leu 
325 330 335 
Gly Asp Tyr Arg Met Ile Asp Arg Thr Pro Phe Phe Lys Ala Met Trp 
340 345 350 
Arg Glu Ala Lys Glu Cys Ile Tyr Ile Glu Gln Asp Ala Asp Ser Lys 
355 360 365 
His Lys Gly Thr Tyr Trp Tyr His Lys Met 
3'70 375 
<2lO> SEQ ID NO 3 
<2ll> LENGTH: 8 
<2l2> TYPE: PRT 
<2l3> ORGANISM: Crepis palaestina and Vernonia galamensis 
SEQUENCE: 3 
Cys His Glu Cys Gly His His Ala 
l 5 
SEQ ID NO 4 
LENGTH: 8 
TYPE: PRT 
ORGANISM: Crepis palaestina and Vernonia galamensis 
SEQUENCE: 4 
His Asp Val Thr His Thr His Val 
l 5 
SEQ ID NO 5 
LENGTH: 26 
TYPE: DNA 
ORGANISM: Stokesia laevis 
SEQUENCE: 5 
cgcaacctgg attcgctcac gctcgg 26 
SEQ ID NO 6 
LENGTH: 27 
TYPE: DNA 
ORGANISM: Stokesia laevis 
SEQUENCE: 6 
cccagctcag gacttactcc acatacg 27 
SEQ ID NO '7 
LENGTH: 32 
TYPE: DNA 
ORGANISM: Artificial Sequence 
FEATURE: 
OTHER INFORMATION: Artificial SteXpF primer of unknown origin 
SEQUENCE: '7 
gacgcgtctt cccatgtcgg attcatatga tg 32 
SEQ ID NO 8 
LENGTH: 37 
TYPE: DNA 
ORGANISM: Artificial Sequence 
FEATURE: 
OTHER INFORMATION: Artificial SteXpR primer of unknown origin 
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ggaaattcag tcaccggaat caccattcca acacaagttc gattgataac gatgaagttt 480 
acattccgaa aagcaagtcc aaactcgcgc gtatctataa acttcttaac aacccacctg 540 
gtcggctgtt ggttttgatt atcatgttca ccctaggatt tcctttatac ctcttgacaa 600 
atatttccgg caagaaatac gacaggtttg ccaaccactt cgaccccatg agtccaattt 660 
tcaaagaacg tgagcggttt caggtcttcc tttcggatct tggtcttctt gccgtgtttt 720 
atggaattaa agttgctgta gcaaataaag gagctgcttg ggtagcgtgc atgtatggag 780 
ttccggtatt aggcgtattt acctttttcg atgtgatcac cttcttgcac cacacccatc 840 
agtcgtcgcc tcattatgat tcaactgaat ggaactggat cagaggggcc ttgtcagcaa 900 
tcgataggga ctttggattc ctgaatagtg ttttccatga tgttacacac actcatgtca 960 
tgcatcattt gttttcatac attccacact atcatgcaaa ggaggcaagg gatgcaatca 1020 
agccaatctt gggcgacttt tatatgatcg acaggactcc aattttaaaa gcaatgtgga 1080 
gagagggcag ggagtgcatg tacatcgagc ctgatagcaa gctcaaaggt gtttattggt 1140 
atcataaatt gtgatcatat gcaaaatgca catgcatttt caaaccctct agttacgttt 1200 
gttctatgta taataaaccg ccggtccttt ggttgactat gcctaagcca ggcgaaacag 1260 
ttaaataata tcggtatgat gtgtaatgaa agtatgtggt tgtctggttt tgttgctatg 1320 
aaagaaagta tgtggttgtc ggtc 1344 
The invention claimed is: 
1. An isolated nucleic acid molecule comprising a nucle 
otide sequence selected from the group consisting of: (a) the 
nucleotide sequence of SEQ ID NO: 1; (b) the nucleotide 
sequence Which is the full-length complement of (a); and (c) 
a nucleotide sequence Which hybridiZes under high strin 
gency conditions to the complement of SEQ ID NO: 1, 
Wherein said high stringency conditions comprise a Wash in 
0.2><SSC at 65° C. for 15 minutes, and Wherein said nucle 
otide sequence encodes a protein having delta lZ-fatty acid 
epoxygenase activity. 
2. A chimeric DNA construct comprising the isolated 
nucleic acid molecule of claim 1 operably linked to at least 
one regulatory sequence that alloWs the expression of the 
nucleic acid molecule in a host cell. 
3. The chimeric DNA construct according to claim 
Wherein the at least one regulatory sequence alloWs expres 
sion of the nucleic acid molecule in a bacterial, fungal, insect 
or plant seed cell. 
4. The chimeric DNA construct according to claim 2 
Wherein the at least one regulatory sequence is a phaseolin 
promoter. 
5. A vector comprising the chimeric DNA construct 
according to claim 2. 
6. A transformed host cell comprising an isolated nucleic 
acid molecule comprising a nucleotide sequence selected 
from the group consisting of: (a) the nucleotide sequence of 
SEQ ID NO: 1; (b) the nucleotide sequence Which is the 
full-length complement of (a); and (c) a nucleotide sequence 
Which hybridiZes under high stringency conditions to the 
complement of SEQ ID NO: 1, Wherein said high stringency 
conditions comprise a Wash in 0.2><SSC at 650 C. for 15 
minutes, and Wherein said nucleotide sequence encodes a 
protein having delta l2-fatty acid epoxygenase activity. 
35 
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7. An isolated host cell comprising a vector Which com 
prises an isolated nucleic acid molecule having a nucleotide 
sequence selected from the group consisting of: (a) the 
nucleotide sequence of SEQ ID NO: 1; (b) the nucleotide 
sequence Which is the full-length complement of (a); and (c) 
a nucleotide sequence Which hybridiZes under high strin 
gency conditions to the complement of SEQ ID NO: 1, 
Wherein said high stringency conditions comprise a Wash in 
0.2><SSC at 650 C. for 15 minutes, and Wherein said nucle 
otide sequence encodes a protein having delta l2-fatty acid 
epoxygenase activity, and Wherein the nucleotide sequence 
is operably linked to at least one regulatory sequence that 
alloWs the expression of the nucleotide sequence in the host 
cell. 
8. The host cell of claim 7 Wherein the host cell is selected 
from the group consisting of yeast, bacterium, insect and 
plant seed cell. 
9. A transgenic plant seed cell comprising an isolated 
nucleic acid molecule comprising a nucleotide sequence 
selected from the group consisting of: (a) the nucleotide 
sequence of SEQ ID NO: 1; (b) the nucleotide sequence 
Which is the full-length complement of (a); and (c) a 
nucleotide sequence Which hybridiZes under high stringency 
conditions to the complement of SEQ ID NO: 1, Wherein 
said high stringency conditions comprise a Wash in 0.2><SSC 
at 650 C. for 15 minutes, and Wherein said nucleotide 
sequence encodes a protein having delta l2-fatty acid 
epoxygenase activity. 
10. Atransgenic plant seed cell comprising a vector Which 
comprises an isolated nucleic acid molecule having a nucle 
otide sequence selected from the group consisting of: (a) the 
nucleotide sequence of SEQ ID NO: 1; (b) the nucleotide 
sequence Which is the full-length complement of (a); and (c) 
a nucleotide sequence Which hybridiZes under high strin 
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gency conditions to the complement of SEQ ID NO: 1, 
wherein said high stringency conditions comprise a Wash in 
0.2><SSC at 65° C. for 15 minutes, and Wherein said nucle 
otide sequence encodes a protein having delta 12-fatty acid 
epoxygenase activity, and Wherein the nucleotide sequence 
22 
is operably linked to at least one regulatory sequence that 
alloWs the expression of the nucleotide sequence in the plant 
seed cell. 
